| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
(TNF-
) and Soluble TNF Receptors in Patients with Anorexia Nervosa1
College of Medical Technology (Y.N.) and Department of Psychiatry (S.H.) Kyoto University, Kyoto 606-8507; Takagi Psychiatric Clinic (R.T.), Kyoto 606-8507; Kansai-Denryoku-Hospital (A.T.), Osaka 553-0003; and Mitsubishi Kagaku Bio-Clinical Laboratory Inc. (F.K.), Tokyo 174-0056, Japan
Address all correspondence and requests for reprints to: Yoshikatsu Nakai, M.D., College of Medical Technology, Kyoto University, 53 Kawaharacho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan. E-mail: YN{at}itan.kyoto-u.ac.jp
Tumor necrosis factor-
(TNF-
) is a cytokine with numerous
immunological and metabolic activities. To study the role of TNF-
on
the pathophysiology of anorexia nervosa and its complications, plasma
concentrations of TNF-
, 2 soluble TNF receptors (sTNF-RI and
sTNF-RII), and leptin were measured in 20 female patients with anorexia
nervosa (AN) and 20 age-matched normal women (N). Plasma TNF-
concentrations in AN were significantly higher than those in N
(4.1 ± 0.6 pg/mL vs. 1.6 ± 0.1 pg/mL;
P < 0.01). Although no significant difference was
observed in plasma sTNF-RI concentrations between the two groups,
plasma sTNF-RII concentrations in AN were significantly higher than
those in N (2094.0 ± 138.5 pg/mL vs. 1569.5 ±
84.0 pg/mL; P < 0.01). Plasma concentrations of
TNF-
and sTNF-RII after treatment of 8 anorectic patients were not
different from those before treatment, although body fat mass and
plasma leptin concentrations significantly increased after treatment.
Plasma TNF-
concentrations were not related to body fat mass in
anorectic patients. These results suggest that the adipose tissue may
not be the immediate source of TNF-
in anorectic patients and that
TNF-
may contribute to the pathophysiology of immunological and
metabolic abnormalities in anorexia nervosa. .
This article has been cited by other articles:
![]() |
F. M. H. van Dielen, W. A. Buurman, M. Hadfoune, J. Nijhuis, and J. W. Greve Macrophage Inhibitory Factor, Plasminogen Activator Inhibitor-1, Other Acute Phase Proteins, and Inflammatory Mediators Normalize as a Result of Weight Loss in Morbidly Obese Subjects Treated with Gastric Restrictive Surgery J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 4062 - 4068. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tagami, N. Satoh, T. Usui, K. Yamada, A. Shimatsu, and H. Kuzuya Adiponectin in Anorexia Nervosa and Bulimia Nervosa J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1833 - 1837. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Pannacciulli, R. Vettor, G. Milan, M. Granzotto, A. Catucci, G. Federspil, P. De Giacomo, R. Giorgino, and G. De Pergola Anorexia Nervosa Is Characterized by Increased Adiponectin Plasma Levels and Reduced Nonoxidative Glucose Metabolism J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1748 - 1752. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hotta, I. Fukuda, K. Sato, N. Hizuka, T. Shibasaki, and K. Takano The Relationship between Bone Turnover and Body Weight, Serum Insulin-Like Growth Factor (IGF) I, and Serum IGF-Binding Protein Levels in Patients with Anorexia Nervosa J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 200 - 206. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |